progesterone: be prescribed during menopause

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents hormone
Weight: 0.73
, drug
Weight: 0.57
, ingredient
Weight: 0.56
, substance
Weight: 0.55
Siblings estrogen
Weight: 0.39
, glucocorticoid
Weight: 0.39
, oxytocin
Weight: 0.39
, vasopressin
Weight: 0.38
, prolactin
Weight: 0.38

Related properties

Property Similarity
be prescribed during menopause 1.00
be used in menopause 0.94
be prescribed during pregnancy 0.90
be prescribed in pregnancy 0.89
be prescribed in early pregnancy 0.89
be known as hormone of pregnancy 0.81
during menstruation 0.81
be called hormone of pregnancy 0.81
be called pregnancy hormone 0.81
be hormone of pregnancy 0.81

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.51
Similarity weight: 0.81
Evidence: 0.79
¬ Remarkable(progesterone, be prescribed during menopause) ⋁
Evidence: 0.63
¬ Remarkable(estrogen, during menstruation)

Remarkability from sibling implausibility

0.47
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.81
Evidence: 0.80
Plausible(progesterone, be prescribed during menopause) ⋁
Evidence: 0.63
Remarkable(estrogen, during menstruation) ⋁
Evidence: 0.62
¬ Plausible(estrogen, during menstruation)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.80
Plausible(progesterone, be prescribed during menopause) ⋁
Evidence: 0.93
¬ Salient(progesterone, be prescribed during menopause)

Similarity expansion

0.75
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.94
Evidence: 0.93
Salient(progesterone, be prescribed during menopause) ⋁
Evidence: 0.79
¬ Salient(progesterone, be used in menopause)
0.73
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.94
Evidence: 0.78
Typical(progesterone, be prescribed during menopause) ⋁
Evidence: 0.41
¬ Typical(progesterone, be used in menopause)
0.72
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.90
Evidence: 0.93
Salient(progesterone, be prescribed during menopause) ⋁
Evidence: 0.82
¬ Salient(progesterone, be prescribed during pregnancy)
0.71
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.89
Evidence: 0.93
Salient(progesterone, be prescribed during menopause) ⋁
Evidence: 0.85
¬ Salient(progesterone, be prescribed in pregnancy)
0.71
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.94
Evidence: 0.80
Plausible(progesterone, be prescribed during menopause) ⋁
Evidence: 0.55
¬ Plausible(progesterone, be used in menopause)
...

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.96
Similarity weight: 1.00
Evidence: 0.93
Salient(progesterone, be prescribed during menopause) ⋁
Evidence: 0.78
¬ Typical(progesterone, be prescribed during menopause) ⋁
Evidence: 0.79
¬ Remarkable(progesterone, be prescribed during menopause)

Typical implies Plausible

0.40
Rule weight: 0.48
Evidence weight: 0.84
Similarity weight: 1.00
Evidence: 0.80
Plausible(progesterone, be prescribed during menopause) ⋁
Evidence: 0.78
¬ Typical(progesterone, be prescribed during menopause)

Typicality and Rermarkability incompatibility between siblings

0.05
Rule weight: 0.14
Evidence weight: 0.49
Similarity weight: 0.81
Evidence: 0.79
¬ Remarkable(progesterone, be prescribed during menopause) ⋁
Evidence: 0.65
¬ Typical(estrogen, during menstruation)